MTOR and hepatocellular carcinoma: Most importantly, FOXH1 HA22T tumors were considerably suppressed when we administrated them with 2 mg/kg rapamycin (Figure 6A, 6B), strengthening the notion that the contribution of FOXH1 to HCC progression was at least partially dependent of mTOR signaling.